Millrace Asset Group Inc. Lowers Stock Position in Inogen, Inc. (NASDAQ:INGN)

Millrace Asset Group Inc. decreased its holdings in shares of Inogen, Inc. (NASDAQ:INGN) by 12.7% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 127,285 shares of the medical technology company’s stock after selling 18,599 shares during the period. Millrace Asset Group Inc.’s holdings in Inogen were worth $1,235,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of the business. Divisadero Street Capital Management LP grew its holdings in Inogen by 682.3% during the second quarter. Divisadero Street Capital Management LP now owns 2,346,766 shares of the medical technology company’s stock worth $19,079,000 after acquiring an additional 2,046,766 shares during the period. Connor Clark & Lunn Investment Management Ltd. boosted its position in shares of Inogen by 312.5% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 174,625 shares of the medical technology company’s stock worth $1,694,000 after purchasing an additional 132,287 shares in the last quarter. AQR Capital Management LLC boosted its position in shares of Inogen by 29.3% during the 2nd quarter. AQR Capital Management LLC now owns 570,994 shares of the medical technology company’s stock worth $4,642,000 after purchasing an additional 129,307 shares in the last quarter. Sanctuary Advisors LLC acquired a new position in shares of Inogen during the 2nd quarter worth $651,000. Finally, Monaco Asset Management SAM purchased a new position in shares of Inogen in the 2nd quarter valued at about $610,000. 89.94% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently commented on INGN shares. StockNews.com downgraded shares of Inogen from a “buy” rating to a “hold” rating in a report on Thursday, November 21st. Needham & Company LLC reissued a “hold” rating on shares of Inogen in a research note on Friday, November 8th.

Inogen Stock Up 4.3 %

Shares of INGN stock opened at $9.78 on Tuesday. The stock has a market cap of $232.96 million, a P/E ratio of -4.35 and a beta of 1.04. Inogen, Inc. has a fifty-two week low of $4.93 and a fifty-two week high of $13.33. The business has a fifty day simple moving average of $9.60 and a 200-day simple moving average of $9.63.

Inogen Company Profile

Inogen, Inc, a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.